News | Artificial Intelligence | December 07, 2021

Study results demonstrate the accuracy of AI-based ultrasound software, enabling a quicker detection of right ventricle dysfunction caused by COVID-19, pulmonary embolism, and more

DiA Imaging Analysis, a leading provider of advanced AI-based software for ultrasound analysis, was featured in a recent study presented by a team of cardiac physicians from Mount Sinai's Icahn School of Medicine at the American Heart Association meeting.

December 7, 2021 — DiA Imaging Analysis, a leading provider of advanced AI-based software for ultrasound analysis, was featured in a recent study presented by a team of cardiac physicians from Mount Sinai's Icahn School of Medicine at the American Heart Association meeting. The breakthrough study demonstrated the accuracy of LVivo RV, the company's AI for right ventricle function analysis, validating its sensitivity and specificity results compared to Cardiac MRI (CMR).

Right Ventricle (RV) size and function are vital indicators of cardiac dysfunction, including pulmonary embolism (PE), pulmonary hypertension, and right heart failure. Amid the COVID-19 pandemic, cardiac ultrasound imaging includes assessment of the RV to detect RV dysfunction, commonly seen in patients with COVID-19. Although common, RV function analysis using an ultrasound device is difficult and often requires additional examination due to the RV's challenging geometry. 

The recent study of 125 patients compared DiA's right heart AI-based software to CMR. Results demonstrated high sensitivity and specificity when compared to CMR, the gold standard of cardiac imaging. The study concluded that DiA's automated AI-based right heart analysis for automated RV function quantification has the potential to accurately and instantly detect evidence of right heart dysfunction at the echo lab and near the bedside.

Dr. Martin Goldman, professor of cardiology at Mount Sinai and a leading author of the study said, "As echo is the first imaging triage modality used for scanning suspected heart issues, this study validated the potential of adding AI as part of our cardiac ultrasound workflow." 

"We are proud to share that leading physicians from the Icahn School of Medicine at Mount Sinai, a globally ranked program, have validated our FDA-approved AI software," said Hila Goldman-Aslan, CEO and co-founder of DiA Imaging Analysis. "The study demonstrated that LVivo RV can provide an automated and accurate solution to the critical analysis of the right ventricle function using ultrasound." 

The study, Validation of Artificial Intelligence for Assessing Right Ventricular Function by Transthoracic Echocardiography, was conducted by Brian Hsia, Ashton Lai, Rajeev Samtani, Solomon Bienstock, Steve Liao, Eric Stern, Gina LaRocca, Javier Sanz, Stamatios Lerakis, Gregg W Stone, Lori Croft, and Martin Goldman, of the Icahn School of Medicine at Mount Sinai, New York, NY. The results were presented to the American Heart Association on November 15, 2021. The study was published in Circulation Magazine, Volume 144, Issue 1.

For more information: www.dia-analysis.com/

Related RSNA2021 content

Related Content

Feature | Ultrasound Imaging | By Lennard M. Gettz, and Noelle Cutter, Ph.D. Edited by Robert L. Bard, M.D. DABR, FASL

Since the advent of ultrasound scanning in the 1950s, the global movement to develop and expand its diagnostic features ...

Time January 21, 2022
arrow
News | Radiology Business

January 21, 2022 — IBM and Francisco Partners, a leading global investment firm that specializes in partnering with ...

Time January 21, 2022
arrow
News | Artificial Intelligence

January 20, 2022 — Leading health tech firm Qure.ai has gained 510(k) clearance from the Food and Drug Administration ...

Time January 20, 2022
arrow
Feature | Radiology Business | By Jef Williams

The Great Resignation has impacted every industry, including ours. While this movement will be studied for years to come ...

Time January 20, 2022
arrow
Feature | Vendor Neutral Archive (VNA)

Vendor neutral archives (VNAs) have become a staple within the healthcare IT system. At the Radiological Society of ...

Time January 20, 2022
arrow
Feature | Artificial Intelligence | By Dave Fornell, ITN Editor

Artificial intelligence (AI) has found a unique niche to help automate the activation of acute care teams for pulmonary ...

Time January 19, 2022
arrow
Sponsored Content | Case Study | Ultrasound Imaging

The most common cause of chronic liver disease? Nonalcoholic fatty liver disease (NAFLD). With 25% of the world’s ...

Time January 19, 2022
arrow
News | Coronavirus (COVID-19)

January 14, 2022 — The COVID-19 pandemic took the world by storm in early 2020 and has become since then the leading ...

Time January 14, 2022
arrow
News | Mammography

January 14, 2022 — Computer engineers and radiologists at Duke University have developed an artificial intelligence ...

Time January 14, 2022
arrow
Videos | Artificial Intelligence

Here are two examples of artificial intelligence (AI) driven pulmonary embolism (PE) response team apps featured by ...

Time January 13, 2022
arrow
Subscribe Now